Effect of Mulberry Leaf Extract on Blood Glucose
- Conditions
- Prediabetic State
- Interventions
- Dietary Supplement: Mulberry leaf extractDietary Supplement: Placebo
- Registration Number
- NCT01385865
- Lead Sponsor
- Ewha Womans University
- Brief Summary
The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose in subjects with impaired fasting glucose.
- Detailed Description
The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose in subjects with impaired fasting glucose. After 2 weeks run-in period for wash-out, subjects will randomly assigned to two groups, i.e. control group (placebo) or mulberry leaf extract group. They will intake placebo or mulberry leaf extract for 4 weeks. Biomarkers will be analyzed in blood samples in 0 and 4 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Age: over 20 years
- Fasting glucose: 100mg/dl ≤ ~ ≤ 125mg/dl
- HbA1c: < 6.5%
- Subject who has taken medicines, Chinese medicines and Health/Functional Foods which can affect glucose metabolism in 30 days prior to screening visit
- Subject who has taken part in other clinical trials in 30 days prior to screening visit
- Subject who is pregnant or breast feeding
- Subject who lost body weight over 4 kg in 30 days prior to screening visit
- Alcoholic
- Heavy smoker (≥ 20 cigarettes/day)
- Subject who has heart failure, coronary artery disease, uncontrolled hypertension (≥ 140/90mmHg), diabetes (fasting blood glucose ≥ 126mg/dL), renal dysfunction, liver failure, hyperthyroidism, hypothyroidism, cancer or mental disease
- Subject who has an allergy to the ingredients of study product
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mulberry leaf extract Mulberry leaf extract - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Blood glucose change with meal tolerance test 0wk
- Secondary Outcome Measures
Name Time Method Malondialdehyde 0, 4wk Blood glucose change with meal tolerance test 4wk Insulin and C-peptide changes with meal tolerance test 0, 4 wk Fasting blood glucose 0, 4 wk Insulin 0, 4wk C-peptide 0, 4wk Glycated albumin 0, 4wk High sensitivity C-reactive protein 0, 4wk Oxidized low-density lipoprotein 0, 4wk Lipid profile (triglyceride, total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, high-density lipoprotein cholesterol) 0, 4wk
Trial Locations
- Locations (1)
Bundang CHA Medical Center
🇰🇷Seongnam, Gyeonggi-Do, Korea, Republic of